François Conquet is the founder of Exciva. Exciva has raised $59M in total funding. Latest round: Series B. Based in Heidelberg, Germany.
François Conquet is the CEO of Exciva, a Heidelberg, Germany-based biopharmaceutical company focused on developing novel therapeutic compounds for neuropsychiatric conditions, specifically clinical-stage treatments for agitation and other neuropsychiatric symptoms in Alzheimer's disease. Exciva recently closed a €51 million ($59m) Series B financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library